Business Trends

Oct 13, 2015
By BioPharm International Editors
A CPhI report predicts how two potential mega free-trade deals, one among Pacific-Rim countries and the other between the US and EU, could affect pharmaceutical companies.
Oct 13, 2015
By BioPharm International Editors
A CPhI report suggests that the pharma industry should be careful not to outsource to lower labor-cost countries rather than investing in manufacturing technology and innovation.
Oct 02, 2015
BioPharm International
How can the industry achieve excellence when its training programs are geared to meeting minimum regulatory guidelines?
Oct 02, 2015
BioPharm International
Aging populations and increased access to healthcare translates into opportunities for biopharmaceutical companies. JLL’s 2015 Life Sciences Outlook report highlights global clusters worth watching.
Oct 02, 2015
BioPharm International
This article examines trends in biopharma post-grant patent review and projects what the future holds in store.
Oct 02, 2015
BioPharm International
Aging populations and increased access to healthcare translates into opportunities for biopharmaceutical companies. JLL’s 2015 Life Sciences Outlook report highlights global clusters worth watching.
Oct 01, 2015
BioPharm International
In the development of biopharmaceuticals and pharmaceuticals, the line is blurring.
Sep 01, 2015
BioPharm International
China’s emergence as a significant commercial market is forcing manufacturers to re-evaluate their overall business model.
Aug 07, 2015
European Union regulators said Pfizer must divest its infliximab biosimilar candidate and some sterile injectables for the merger with Hospira to be completely approved.
Aug 01, 2015
BioPharm International
FDA notes progress in drug development, but cites scientific and funding roadblocks.
native1_300x100
lorem ipsum